Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pectoral Blocks for Pain in Gender Affirmation Breast Surgery
NCT04474366Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Jun 2020
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in postoperative pain, sponsored by University of California, San Francisco. Started Jun 2020; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04474366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04474366.